birmingham tirzepatide al FDA says shortage of GLP-1 drug tirzepatide is over Clinical Trial Talks: Surmount 2

In SURMOUNT-4, all participants received tirzepatide (Mounjaro, Eli Lilly) during a lead-in phase, with the study population achieving a mean weight loss of 20.2% at 36 weeks

Obsessive, intrusive thoughts about eating known as food noise can be quieted through semaglutide drugs such as Ozempic, new research has revealed, further boosting the effectiveness of these treatments for weight loss.

NBCs Stephanie Gosk reports for TODAY on how soon it could be approved to be prescribed for patients.

For long-term adherence, and for the emotional and psychological relationship patients have with food, this distinction is enormously significant

Interest in semaglutide, sold as Wegovy and Ozempic, is exploding.